International Workshop
on COVID-19 Lessons to Inform
Pandemic Influenza Response
PROCEEDINGS OF A WORKSHOP
Megan Snair and Mariya Dimitrova, Rapporteurs
NATIONAL ACADEMY OF MEDICINE
THE NATIONAL ACADEMIES PRESS
Washington, DC
www.nap.edu
THE NATIONAL ACADEMIES PRESS 500 Fifth Street, NW, Washington, DC 20001
This activity was supported by a contract between the National Academy of Sciences and the Office of Global Affairs with the U.S. Department of Health and Human Services. Any opinions, findings, conclusions, or recommendations expressed in this publication do not necessarily reflect the views of any organization or agency that provided support for the project.
International Standard Book Number-13: 978-0-309-26967-4
International Standard Book Number-10: 0-309-26967-9
Digital Object Identifier: https://doi.org/10.17226/26352
Additional copies of this publication are available from the National Academies Press, 500 Fifth Street, NW, Keck 360, Washington, DC 20001; (800) 624-6242 or (202) 334-3313; http://www.nap.edu.
Copyright 2022 by the National Academy of Sciences. All rights reserved.
Printed in the United States of America
Suggested citation: National Academy of Medicine. 2022. International workshop on COVID-19 lessons to inform pandemic influenza response: Proceedings of a workshop. Washington, DC: The National Academies Press. https://doi.org/10.17226/26352.
The National Academy of Sciences was established in 1863 by an Act of Congress, signed by President Lincoln, as a private, nongovernmental institution to advise the nation on issues related to science and technology. Members are elected by their peers for outstanding contributions to research. Dr. Marcia McNutt is president.
The National Academy of Engineering was established in 1964 under the charter of the National Academy of Sciences to bring the practices of engineering to advising the nation. Members are elected by their peers for extraordinary contributions to engineering. Dr. John L. Anderson is president.
The National Academy of Medicine (formerly the Institute of Medicine) was established in 1970 under the charter of the National Academy of Sciences to advise the nation on medical and health issues. Members are elected by their peers for distinguished contributions to medicine and health. Dr. Victor J. Dzau is president.
The three Academies work together as the National Academies of Sciences, Engineering, and Medicine to provide independent, objective analysis and advice to the nation and conduct other activities to solve complex problems and inform public policy decisions. The National Academies also encourage education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science, engineering, and medicine.
Learn more about the National Academies of Sciences, Engineering, and Medicine at www.nationalacademies.org.
Consensus Study Reports published by the National Academies of Sciences, Engineering, and Medicine document the evidence-based consensus on the study’s statement of task by an authoring committee of experts. Reports typically include findings, conclusions, and recommendations based on information gathered by the committee and the committee’s deliberations. Each report has been subjected to a rigorous and independent peer-review process, and it represents the position of the National Academies on the statement of task.
Proceedings published by the National Academies of Sciences, Engineering, and Medicine chronicle the presentations and discussions at a workshop, symposium, or other event convened by the National Academies. The statements and opinions contained in proceedings are those of the participants and are not endorsed by other participants, the planning committee, or the National Academies.
For information about other products and activities of the National Academies, please visit www.nationalacademies.org/about/whatwedo.
PLANNING COMMITTEE ON INTERNATIONAL WORKSHOP ON COVID-19 LESSONS TO INFORM PANDEMIC INFLUENZA RESPONSE1
HEIDI LARSON (Chair), Founding Director, Vaccine Confidence Project, London School for Hygiene & Tropical Medicine
BEN ADEIZA ADINOYI, Head, Health and Care Unit, Africa Region, International Federation of Red Cross and Red Crescent Societies
PHIONAH ATUHEBWE, Vaccines Introduction Medical Officer, World Health Organization-Africa
PAULA BARBOSA, Associate Director of Vaccines Policy, International Federation of Pharmaceutical Manufacturers & Associations
MALIK PEIRIS, Chair of Virology, The University of Hong Kong
JOHN SIMPSON, Head, Emergency Response Department; Deputy Director, Health Protection Directorate, Public Health England
JULIE SWANN, Department Head, Industrial and Systems Engineering, North Carolina State University
BEVERLY TAYLOR, Head of Influenza Scientific Affairs, World Health Organization; International Federation of Pharmaceutical Manufacturers & Associations Lead, Seqirus Vaccines
CIRO UGARTE, Director, Health Emergencies, Pan American Health Organization
National Academy of Medicine Staff
MORGAN KANAREK, Director of Operations and Chief of Staff
JOHANNA GUSMAN, International Health Programs Officer
Consultants
MEGAN SNAIR, SGNL Solutions
MARIYA DIMITROVA, SGNL Solutions
___________________
1 The National Academies of Sciences, Engineering, and Medicine’s planning committees are solely responsible for organizing the workshop, identifying topics, and choosing speakers. The responsibility for the published Proceedings of a Workshop rests with the workshop rapporteurs and the institution.
INTERNATIONAL COMMITTEE ON ADVANCING PANDEMIC AND SEASONAL INFLUENZA VACCINE PREPAREDNESS AND RESPONSE
MARTIN FRIEDE (Co-Chair), Unit Lead, World Health Organization
PRASHANT YADAV (Co-Chair), Senior Fellow, Center for Global Development
RIPLEY BALLOU, Principal Investigator, ADVANCE Program, IAVI
NORMAN W. BAYLOR, President and Chief Executive Officer, Biologics Consulting
THOMAS CUENI, Director General, International Federation of Pharmaceutical Manufacturers & Associations
KEIJI FUKUDA, Director and Clinical Professor, School of Public Health, LKS Faculty of Medicine, The University of Hong Kong
PATRICIA GARCÍA, Professor, School of Public Health and Administration, Cayetano Heredia University
ANURADHA GUPTA, Deputy Chief Executive Officer, Gavi, the Vaccine Alliance
RICHARD HATCHETT, Chief Executive Officer, Coalition for Epidemic Preparedness Innovations
DANIEL B. JERNIGAN, Director, Influenza Division, National Center for Immunization and Respiratory Diseases, U.S. Centers for Disease Control and Prevention; Captain, U.S. Public Health Service (retired)
ETLEVA KADILLI, Director, Supply Division, UNICEF
LAWRENCE KERR, Director, Office of Pandemics and Emerging Threats, Office of Global Affairs, U.S. Department of Health and Human Services
HEIDI LARSON, Founding Director, Vaccine Confidence Project, London School of Hygiene & Tropical Medicine
PETER SANDS, Executive Director, The Global Fund to Fight AIDS, Tuberculosis and Malaria
JOHN SIMPSON, Head, Emergency Response Department; Deputy Director, Health Protection Directorate, Public Health England
KANTA SUBBARAO, Director, World Health Organization Collaborating Centre for Reference and Research on Influenza at the Victorian Infectious Disease Reference Laboratory in Melbourne
BEVERLY TAYLOR, Head of Influenza Scientific Affairs, World Health Organization; International Federation of Pharmaceutical Manufacturers & Associations Lead, Seqirus Vaccines
National Academy of Medicine Staff
MORGAN KANAREK, Director of Operations and Chief of Staff
JOHANNA GUSMAN, International Health Programs Officer
Reviewers
This Proceedings of a Workshop was reviewed in draft form by individuals chosen for their diverse perspectives and technical expertise. The purpose of this independent review is to provide candid and critical comments that will assist the National Academies of Sciences, Engineering, and Medicine in making each published proceedings as sound as possible and to ensure that it meets the institutional standards for quality, objectivity, evidence, and responsiveness to the charge. The review comments and draft manuscript remain confidential to protect the integrity of the process.
We thank the following individuals for their review of this proceedings:
Although the reviewers listed above provided many constructive comments and suggestions, they were not asked to endorse the content of the proceedings nor did they see the final draft before its release. The review of this proceedings was overseen by KRISTINE GEBBIE, Flinders University School of Nursing and Midwifery. She was responsible for making certain that an independent examination of this proceedings was carried out in accordance with standards of the National Academies and that all review comments were carefully considered. Responsibility for the final content rests entirely with the rapporteurs and the National Academies.
This page intentionally left blank.
Contents
National Academy of Medicine Initiative
Organization of the Proceedings
2 GLOBAL COORDINATION, PARTNERSHIPS, AND FINANCING
Global End-to-End Governance and Financing
Approaches to Optimize Available Vaccines
Global Quality Standards for Surveillance and Risk Assessment
A More Unified One Health System
3 VACCINE RESEARCH AND DEVELOPMENT
Exploring Promising Technology and Steps for the Future
4 VACCINE DISTRIBUTION AND SUPPLY CHAIN
Upstream Supply Chain Challenges and Downstream Implications
Contributing to Better Information Sharing
Leveraging Current Platforms and Emerging Lessons for Future Planning
Improving Equity in Delivery and Supply Chain
Reflections to Better Prepare for Future Pandemics
5 RESEARCH TRANSLATION AND COMMUNICATION
Research of Nonpharmaceutical Interventions
Clear Communication in a Pandemic
Equity in Research and Communication
Understanding the Importance of Context
Acronyms and Abbreviations
| ACT |
Access to COVID-19 Tools |
| Africa CDC |
Africa Centres for Disease Control and Prevention |
| AIRA |
Africa Infodemic Response Alliance |
| AMC |
advanced market commitment |
| AVMI |
African Vaccine Manufacturing Initiative |
| CEPI |
Coalition for Epidemic Preparedness Innovations |
| CFSC |
Communication for Social Change |
| CHW |
community health worker |
| COVAX |
COVID-19 Vaccines Global Access |
| COVID-19 |
coronavirus disease 2019 |
| DCVMN |
Developing Countries Vaccine Manufacturers Network |
| EMA |
European Medicines Agency |
| GISAID |
Global Initiative on Sharing Avian Influenza Data |
| GloPID-R |
Global Research Collaboration for Infectious Disease Preparedness |
| HPV |
human papillomavirus |
| IFPMA |
International Federation of Pharmaceutical Manufacturers & Associations |
| LMIC |
low- and middle-income country |
| LSHTM |
London School of Hygiene & Tropical Medicine |
| NAM |
National Academy of Medicine |
| NPI |
nonpharmaceutical intervention |
| OGA |
Office of Global Affairs (U.S. Department of Health and Human Services) |
| OIE |
World Organisation for Animal Health |
| PACT |
Partnership to Accelerate COVID Testing |
| PAHO |
Pan American Health Organization |
| PPE |
personal protective equipment |
| R&D |
research and development |
| SARS |
severe acute respiratory syndrome |
| UN |
United Nations |
| UNICEF |
United Nations Children’s Fund |
| U.S. CDC |
U.S. Centers for Disease Control and Prevention |
| WHO |
World Health Organization |
| WHO-AFRO |
WHO African Region |
